Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion type Assertion NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_head.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion description "[IL-11Ralpha is a candidate target for translational clinical trials against advanced and metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_provenance.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion evidence source_evidence_literature NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_provenance.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion SIO_000772 14744752 NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_provenance.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion wasDerivedFrom lhgdn-20090331 NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_provenance.
- NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_assertion wasGeneratedBy ECO_0000203 NP203281.RALkUd3FOU7fMl72tkbip8_Zu6-gEEU0A9qQbVEcf5oFA130_provenance.